After a painful 2016, biotech stocks are recovering this year. What lies ahead? Let's look at 5 biotech ETFs to find out More
Biotech StocksBiotechnology has been one of the fastest advancing industries in the past decade. With new medicine always being synthesized and new ways to fertilize crops, the sector is diverse and prosperous, especially as corporations look for new findings or better efficiency. Subsequently, the biotech stocks are booming and should continue to rise in the future.
Some of the best biotech stocks to buy in 2014 include Amgen (NYSE:AMGN) and Gilead Sciences (NYSE:GILD) although many smaller biotech corporations are on the rise and worth a consideration. Biotech stocks can cure your ailing portfolio and lead you down the road to recovery.
Biotechnology Sector Quote (CIX: MSECTOR5151)
Biotechs have stabilized and offer the potential to deliver substantial returns. Here are 5 biotech stocks that fit our investment criteria More
Biogen just beat fourth-quarter earnings. But BIIB stock won't really get going until the biotech sector as a whole does. More
The volatility of biotech shares makes biotech investing among the most lucrative ways to invest. Here's a great way to start... More
Biotech and pharmaceutical companies headed lower and not because of the election. Here's why you should sell these stocks More
The iShares Nasdaq Biotechnology ETF (IBB) has dwindled over the past few weeks. Now, it's on a hair-thin line of support that bulls and bears alike should watch. More
CELG stock now sits at a critical technical juncture with two paths to take after Celgene experienced a wild ride in late July and August. More
The iShares Nasdaq Biotechnology ETF (IBB) has settled into a constructive-looking phase. The path of least resistance? North! More
While the intermediate-term trend remains intact for the IBB etf, earnings season for large biotech companies could be make-or-break. More